Raphael Pharmaceutical (RAPH) Net Cash Flow (QoQ) (2021 - 2025)
Raphael Pharmaceutical (RAPH) Net Cash Flow (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 347.06% |
| Sep 30, 2025 | 43.33% |
| Jun 30, 2025 | -196.77% |
| Mar 31, 2025 | 247.62% |
| Dec 31, 2024 | 73.75% |
| Sep 30, 2024 | 52.38% |
| Jun 30, 2024 | -394.74% |
| Mar 31, 2024 | 182.61% |
| Dec 31, 2023 | -136.70% |
| Sep 30, 2023 | 157.53% |
| Jun 30, 2023 | 129.20% |
| Mar 31, 2023 | -228.21% |
| Dec 31, 2022 | 587.50% |
| Sep 30, 2022 | -174.07% |
| Jun 30, 2022 | 175.00% |
| Mar 31, 2022 | -162.07% |
| Dec 31, 2021 | 164.09% |
| Sep 30, 2021 | -187.02% |
| Jun 30, 2021 | 344.71% |
| Mar 31, 2021 | -244.07% |